Drug Resistance Clinical Trial
Official title:
Laboratory Aspirin Resistance in Coronary Artery Disease Patients With or Without Diabetes Mellitus
Despite treatment with aspirin a large number of patients suffer a myocardial infarction. It has been speculated that these patients might be "resistant" to aspirin, and studies have indicated that this phenomenon is related to a less favourable prognosis. Furthermore, patients with diabetes mellitus have an increased risk of myocardial infarction and other vascular events and, recently, it has been suggested that diabetics do not respond adequately to aspirin. The purpose of this study is to compare the prevalence of "aspirin resistance" in diabetics and non-diabetics. Furthermore, patients who suffered a myocardial infarction while being treated with aspirin are included. We hypothesize that the prevalence of "aspirin resistance" will be higher among diabetics compared to other patients and to healthy individuals.
A considerable number of patients suffer acute coronary events despite being treated with antiplatelet therapy such as aspirin. Taken together with laboratory findings of a low response to aspirin, the term "aspirin resistance" has been coined. Diabetics have an increased risk of suffering ischemic vascular events and, recently, an increased prevalence of "aspirin resistance" was reported in these patients. The purpose of the present study is to compare the aspirin response in diabetics and non-diabetics in a population with angiogram-verified coronary artery disease. Furthermore, healthy volunteers and patients who suffered a myocardial infarction while being treated with aspirin are included. Eligible patients are identified in the Western Denmark Heart Registry. ;
Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04516395 -
Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae
|
N/A | |
| Terminated |
NCT00319150 -
REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial
|
Phase 3 | |
| Completed |
NCT00389129 -
Danish Aspirin Resistance Trial - Pilot Study
|
N/A | |
| Terminated |
NCT00193947 -
An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy
|
Phase 4 | |
| Enrolling by invitation |
NCT06037564 -
B-free Multistage Trial
|
Phase 4 | |
| Completed |
NCT04326868 -
Human Soil Transmitted Helminths (STH) Resistance to Benzimidazole in School Aged Children Living in Gabon
|
Phase 4 | |
| Completed |
NCT01039480 -
Aspirin and Clopidogrel Resistance Study
|
N/A | |
| Recruiting |
NCT05310370 -
HRD and Resistance to PAPPi in EOC Patients
|
||
| Active, not recruiting |
NCT00457236 -
Effect of Clopidogrel Loading and Risk of PCI
|
N/A | |
| Completed |
NCT02792816 -
Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar
|
N/A | |
| Completed |
NCT01386476 -
(18F)FCWAY and the Blood-Brain Barrier
|
||
| Recruiting |
NCT04990596 -
Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)
|
||
| Recruiting |
NCT03401957 -
The Emergence of RAS Mutations in Metastatic Colorectal Cancer Patients Receiving Cetuximab Treatment
|
N/A | |
| Completed |
NCT04404582 -
Clinical Characteristics for the Critical Ill Patients With Klebsiella Pneumoniae Infection
|
||
| Completed |
NCT02401204 -
Bacterial Transmission Dynamics Study
|
||
| Completed |
NCT03114098 -
Pharmacogenetics Anomaly Research in Children and Adolescents With Pharmacological Resistance to Psychotropic Drugs
|
N/A | |
| Recruiting |
NCT03361267 -
Comparison of Bismuth Containing Quadruple Therapy and Based Tailored Therapy for H. Pylori Infection
|
N/A | |
| Completed |
NCT00302913 -
Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition
|
N/A | |
| Completed |
NCT04833231 -
The Relationship Between Renal Functions and Multi Drug Resistant Organisms
|
||
| Completed |
NCT00965042 -
Effect of Ceftobiprole on Human Intestinal Microflora
|
Phase 1 |